Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-05-18
1997-01-21
Weddington, Kevin E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 3144
Patent
active
055960073
ABSTRACT:
A therapeutic method is provided to alleviate tobacco withdrawal syndrome and/or the symptoms of nicotine withdrawal, comprising administering an amount of cotinine or a pharmaceutically acceptable salt thereof to a human in need of such treatment, which amount is effective to reduce or eliminate at least one of the symptoms of tobacco withdrawal syndrome or nicotine withdrawal.
REFERENCES:
patent: 2981641 (1961-04-01), O'Neill
patent: 3048520 (1962-08-01), Mckennis, Jr. et al.
patent: 3821960 (1974-07-01), Egri
patent: 3867519 (1975-02-01), Michaels
patent: 3870791 (1975-03-01), Haddad et al.
patent: 3870794 (1975-03-01), Hutchinson et al.
patent: 4051842 (1977-10-01), Hazel et al.
patent: 4136177 (1979-01-01), Lin et al.
patent: 4140122 (1979-02-01), Kuhl et al.
patent: 4255415 (1981-03-01), Chrai et al.
patent: 4383529 (1983-05-01), Webster
patent: 4621074 (1986-11-01), Bourne
patent: 4668506 (1987-05-01), Bawa et al.
patent: 4713244 (1987-12-01), Bawa et al.
patent: 4748181 (1988-05-01), Hutchinson et al.
patent: 4788063 (1988-11-01), Fisher et al.
patent: 4835162 (1989-05-01), Abood
patent: 4931279 (1990-06-01), Bawa et al.
patent: 4946853 (1990-08-01), Bannon et al.
patent: 4966916 (1990-10-01), Abood
patent: 5187169 (1993-02-01), Lippiello et al.
patent: 5298257 (1994-03-01), Bannon et al.
"Tobacco Organic Mental Disorder, Caffeine Organic Mental Disorder, Tobacco Dependence", Diagnostic and Statistical Manual of Mental Disorders, 3rd Edition, American Psychiatric Assoc., Washington, D.C., pp. 159-160, 176-178, (1980).
K. E. Bauman, et al., "On the Measurement of Tobacco Use by Adolescents", Am. J. Epidemiol., 130, 327-337, (1989).
M. E. Carroll, et al., "Nicotine Dependence in Rats", Life Sciences, 45, 1381-1388, (1989).
M. Curvall, et al., "The pharmacokinetics of cotinine in plasma and saliva from non-smoking healthy volunteers", Eur. J. Clin. Pharmacol., 38, 281-287, (1990).
E. DiGuisto, et al., "Some Properties of Saliva Cotinine Measurements in Indicating Exposure to Tobacco Smoking", AJPH, 1986, 1245-1246, (1986).
D. F. Glenn, et al., "Synthesis and Mass Spectroscopy of Some Structurally Related Nicotinoids", J. Org. Chem., 43, 2860-2870, (1978).
N. W. Heimstra, et al., "The Effects of Deprivation of Cigarette Smoking on Psychomotor Performance", Ergonomics, 23, 1047-1055, (1980).
R. R. Hutchinson, et al., "Effects of nicotine on avoidance, conditioned suppression and aggression response measures in animals and man", In: Smoking Behavior: Motives and Incentives, W. L. Dunn (ed.), V. H. Winston & Sons, Washington, D.C., pp. 171-196, (1973).
J. R. Idle, "Titrating Exposure to Tobacco Smoke Using Cotinine--A Minefield of Misunderstandings", J. Clin. Epidemiol., 43, 313-317, (1990).
L. Jarczyk, et al., "Serum and Saliva Concentrations of Cotinine on Smokers and Passive Smokers", J. Clin. Chem. Clin. Biochem., 27, 230-231, (1989).
M. Jarvis, et al., "Biochemical Markers of Smoke Absorption and Self Reported Exposure to Passive Smoking", J. Epidemiol. Commun. Health, 38, 335-339, (1984).
J. S. Jordanov, "Cotinine Concentrations in Amniotic Fluid and Urine of Smoking, Passive Smoling and Non-Smoking Pregnant Women at Term and in the Urine of the Neonates on 1st Day of Life", Eur. J. Pediatr., 149, 734-737, (1990).
W. R. Martin, et al., "Physiologic, Subjective, and Behavioral Effects of Amphetamine, Methamphetamine, Ephedrine, Phenmetrazine, and Methylphenidate in Man", Clinical Pharmacol. and Therapeut., 12, 245-258, (1971).
H. McKennis, et al., "Demethylation of Cotinine in vivo", J. Am. Chem. Soc., 81, 3951-3954, (1959).
A. D. McNeill, et al., "Saliva Cotinine as an Indicator of Cigarette Smoking in Adolescents", Brit. J. Addiction, 82, 1355-1360, (1987).
M. P. Noland, et al., "Saliva Cotinine and Thiocyanate: Chemical Indicators of Smokeless Tobacco and Cigarette Use in Adolecents", J. Behavioral Med., 11, 423-433, (1988).
B. Testa, et al., "Circular Dichroic Determination of the Preferred Conformation of Nicotine and Related Chiral Alkaloids in Aqueous Solution", Molecular Pharmacology, 9, 10-16, (1973).
S. G. Thompson, et al., "Relation of Urinary Cotinine Concentrations to Cigarette Smoking and to Exposure to Other People's Smoke", Thorax, 45, 356-361, (1990).
S. T. Tiffany, et al., "The Development and Initial Validation of a Quesionaire on Smoking Urges", Brit. J. Addiction, 86, 1467-1476, (1991).
H. Van Vunakis, et al., "Decreased Serum Cotinine Levels in Smokers of Both Tobacco and Marijuana as Compared with Smokers of Tobacco Only", Pharmacol. Biochem. Behav., 30, 895-898, (1988).
L. E. Wagenknecht, et al., "Racial Differences in Serum Cotinine Levels Among Smokers in the Coronary Artery Risk Development in (Young) Adults Study", AJPH, 80, 1053-1056, (1990).
P. Zeidenberg, et al., "Abstracts of Niocine: cotinine levels in blood during cessation of smoking", Comp. Psychiatry, 18, 93-111, (1977).
M. E. Carroll et al., Life Sci., 45, 1381 (1989).
L. Abood et al., "Specific Binding and Metabolism of (-)- and (+)-[3H]-Nicotine in Isolated Rat Hepatocytes and Hepatocyte Membranes", Arch. Int. Pharmacodyn, 723:62-73 (1985).
R. Barbieri et al., "Nicotine, Cotinine and Anabasine Inhibit Aromatase in Human Trophoblast in Vitro", J. Clin. Invest., 77:1727-1733 (1986).
R. Barbieri et al., "The Effects of Nicotine, Cotinine, and Anabasine on Rat Adrenal 11-beta-hydroxylase and 21-hydroxylase", J. Steroid Biochem., 28:25-28 (1987).
N. Benowitz, "The Use of Biologic Fluid Samples in Assessing Tobacco Smoke Consumption", Measurement in the Analysis and Treatment of Smoking Behavior, J. Grabowski et al. eds., NIDA Research Monograph No. 48, U.S. DHHS, PHS, ADAMHA (1983).
N. Benowitz et al., "Continine Disposition and Effects", Clin. Pharmacol. Ther., 34:604-611 (1983).
N. Benowitz et al., "Inverse Relation Between Serum Cotinine Concentration and Blood Pressure in Cigarette Smokers", Circulation, 80:1309-1312 (1989).
J. Borzelleca et al., "Studies on the Respiratory and Cardiovascular Effects of (-)-Cotinine", J. Pharm. Exper. Therapeutics, 137:313-318 (1962).
E. Bowman et al., "(-)-Cotinine", Biochem. Preparations, 10:36-39 (1963).
E. Bowman et al., "Studies on the Metabolism of (-)-Cotinine in the Human", J. Pharmacol. Exp. Ther., 135:306-311 (1962).
E. Bowman et al., "Disposition and Fate of (-)-Citubube-H3 in the Mouse", J. Pharmac. Exper. Therapeutics, 143:301-308 (1964).
R. Chahine et al., "The in Vitro Effects of Nicotine an Cotinine on Prostacyclin and Thromboxane Biosynthesis", Prostaglandins, Leukotrienes, and Essential Fatty Acids, 40:261-266 (1990).
M. Curvall et al., "Monitoring Absorption by Means of Determination of Nicotine and Cotinine", Arch. Toxicol. Suppl., 9:88-102 (1986), Abstract.
D. Dawson et al., "Evaluation of the Developmental Toxicity of Nicotine and Cotinine with Frog Embryo Teratogenesis Assay: Xenopus", Teratogenesis, Carcinogenesis and Mutagenesis, 8:329-338 (1988).
P. DeSchepper et al., "Kinetics of Cotinine After Oral and Intravenous Administration to Man", Eur. J. Pharmacol., 31:583-588 (1987).
P. Dominiak et al., "Effects of Nicotine and its Major Metabolites on Blood Pressure in Anesthetized Rats", Klinische Wochenschrift, 63:90-92 (1985).
N. Edwards et al., "Doxepin as an Adjunct to Smoking Cessation: A Double-Blind Pilot Study", Am. J. Psychiatry, 146/3:373-376 (Mar. 1989).
W. Frankenburg et al., "The Chemistry of Tobacco Fermentation. I. Conversion of the Alkaloids D. Identification of Cotinine in Fermented Leaves", Cotinine in Fermented Tobacco Leaves, 79:149-151 (Jan. 1957).
K. Fuxe et al., "On the Action of Nicotine and Cotinine on Central 5-Hydroxytryptamine Neurons", Pharmacology, Biochem. & Behavior, 10:671-677 (1979).
S. Goldberg et al., "Nicotine and Some Related Compounds: Effects on Schedule-Controlled Behavior and Discriminative Properties in Rats", Psychopharmacology, 97:295-302 (1989).
D. Hatsukami et al., "Effects of Nicotine Gum on Prevalence and Severity of Withdrawal in Female Cigarette Smokers", J. Substance Abuse, 3:427-440 (1991).
J. Hughes et al., "Signs and Symptoms of Tobacco Withdrawal", Archives of General Psy
Hatsukami Dorothy K.
Keenan Robert M.
Pharmaco Behavioral Associates, Inc.
Weddington Kevin E.
LandOfFree
Therapeutic method to alleviate the craving associated with cess does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic method to alleviate the craving associated with cess, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic method to alleviate the craving associated with cess will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2324468